# ClinicalTrials.gov record NCT00943956

> PeptideScanner retained ClinicalTrials.gov record NCT00943956 at 2026-07-30T21:37:20.823Z. Its registry update date was 2016-05-25, and PeptideScanner's reviewed identity mapping was leuprolide.

- Evidence object: `story:clinicaltrials-gov-nct00943956-leuprolide:v1`
- Evidence domain: Clinical trials
- Date in source: 2016-05-25
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct00943956-leuprolide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct00943956-leuprolide-v1.json
- Content SHA-256: `089f7d0ae36b448e7a6fc28b9fdbd84463daac76e501f60ab85e0a12d0a97fbe`

## Claims and source pins

### Headline

ClinicalTrials.gov record NCT00943956 ([`ctg-observation-nct00943956-2016-05-25-c5304ce387ab`](#source-ctg-observation-nct00943956-2016-05-25-c5304ce387ab))

### Summary

PeptideScanner retained ClinicalTrials.gov record NCT00943956 at 2026-07-30T21:37:20.823Z. Its registry update date was 2016-05-25, and PeptideScanner's reviewed identity mapping was leuprolide. ([`ctg-observation-nct00943956-2016-05-25-c5304ce387ab`](#source-ctg-observation-nct00943956-2016-05-25-c5304ce387ab))

### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT00943956 at 2026-07-30T21:37:20.823Z. Its registry update date was 2016-05-25, and PeptideScanner's reviewed identity mapping was leuprolide. ([`ctg-observation-nct00943956-2016-05-25-c5304ce387ab`](#source-ctg-observation-nct00943956-2016-05-25-c5304ce387ab))

### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct00943956-2016-05-25-c5304ce387ab`](#source-ctg-observation-nct00943956-2016-05-25-c5304ce387ab))

## Sources

<a id="source-ctg-observation-nct00943956-2016-05-25-c5304ce387ab"></a>
- **ClinicalTrials.gov record NCT00943956 · retained source version 2016-05-25:c5304ce387ab5703a8a3162d15b3be23236c9314bc4da6c9c8302196ce16f929** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT00943956) (`ctg-observation-nct00943956-2016-05-25-c5304ce387ab`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT00943956." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct00943956-leuprolide-v1.json SHA-256: 089f7d0ae36b448e7a6fc28b9fdbd84463daac76e501f60ab85e0a12d0a97fbe.